Neurocrine Biosciences, Inc. (BVMF:N1BI34)

Neurocrine Biosciences Ratios and Metrics

Market cap in millions BRL. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 26, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	68,107	77,890	85,477	62,816	60,702	45,018
Market Cap Growth	1.06%	-8.88%	36.07%	3.48%	34.84%	-3.20%
Enterprise Value	62,929	74,392	79,652	58,830	57,973	43,273
Last Close Price	33.48	40.32	42.53	32.30	31.58	23.62
PE Ratio	25.84	29.55	40.49	51.85	74.32	90.18
PS Ratio	4.32	4.94	5.87	6.86	7.71	7.13
PB Ratio	3.80	4.35	5.34	5.80	6.72	5.88
P/TBV Ratio	3.80	4.35	5.34	5.91	6.90	5.88
P/FCF Ratio	16.52	18.89	24.80	35.80	35.56	34.66
P/OCF Ratio	15.80	18.07	23.21	33.20	33.83	31.50
EV/Sales Ratio	4.29	4.72	5.47	6.43	7.37	6.85
EV/EBITDA Ratio	16.85	20.26	20.64	29.14	41.44	35.51
EV/EBIT Ratio	19.27	21.22	21.57	30.71	44.04	37.38
EV/FCF Ratio	15.26	18.04	23.11	33.53	33.96	33.32
Debt / Equity Ratio	0.14	0.14	0.18	0.19	0.15	0.32
Debt / EBITDA Ratio	0.65	0.65	0.68	0.99	0.94	1.88
Debt / FCF Ratio	0.63	0.63	0.82	1.19	0.81	1.89
Net Debt / Equity Ratio	-0.31	-0.31	-0.24	-0.27	-0.42	-0.20
Net Debt / EBITDA Ratio	-1.51	-1.51	-0.99	-1.45	-2.74	-1.24
Net Debt / FCF Ratio	-1.35	-1.35	-1.11	-1.67	-2.25	-1.16
Asset Turnover	0.69	0.69	0.68	0.67	0.67	0.60
Inventory Turnover	16.90	16.90	15.99	16.48	14.85	11.71
Quick Ratio	2.92	2.92	3.06	2.25	2.49	3.65
Current Ratio	3.39	3.39	3.40	2.45	2.70	3.96
Return on Equity (ROE)	16.38%	16.38%	14.16%	12.68%	10.03%	7.17%
Return on Assets (ROA)	9.53%	9.53%	10.71%	8.78%	7.01%	6.82%
Return on Invested Capital (ROIC)	18.73%	20.50%	23.31%	22.75%	17.26%	19.95%
Return on Capital Employed (ROCE)	16.40%	16.40%	18.60%	15.20%	13.60%	11.40%
Earnings Yield	3.87%	3.38%	2.47%	1.93%	1.35%	1.11%
FCF Yield	6.05%	5.29%	4.03%	2.79%	2.81%	2.89%
Buyback Yield / Dilution	1.16%	1.16%	-2.67%	-2.12%	-1.02%	-0.10%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.